Top

Published in:

01-08-2023 | Liraglutide | Review

GLP-1RAs may cause intolerable gastrointestinal AEs

Published in: Reactions Weekly | Issue 1/2023

Excerpt

All glucagon-like peptide-1 receptor agonists (GLP-1RAs) may cause intolerable gastrointestinal (GI) adverse events (AEs) but the risks differ between GLP-1RAs, according to findings of a systematic review and network meta-analysis published in Frontiers of Endocrinology. …

Zhang Z, et al. GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis Frontiers in Endocrinology : 06 Jul 2023. Available from: URL: https://doi.org/10.3389/fendo.2023.1149328

Title: GLP-1RAs may cause intolerable gastrointestinal AEs
Publication date: 01-08-2023
Publisher: Springer International Publishing
Keywords: Liraglutide
Dulaglutid
Exenatide
Cholelithiasis
Semaglutide
Tirzepatide
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-44172-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

GLP-1RAs may cause intolerable gastrointestinal AEs

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Doxepin

Giredestrant/leuprorelin

Acam-2000/smallpox-vaccine

Nivolumab/ulobetasol

Multiple drugs

Anakinra